Please login to the form below

Not currently logged in


This page shows the latest M7824 news and features for those working in and with pharma, biotech and healthcare.

GSK gets serious about immunotherapy with Merck deal worth up to $4.2bn

GSK gets serious about immunotherapy with Merck deal worth up to $4.2bn

The companies say M7824 is being considered for use as a monotherapy and in combination with other assets from both their pipelines. ... We now look forward to harnessing the full potential of M7824 across a broad range of cancer indications as we

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...